Stock·NASDAQ·Industrials
CSX Corporation (CSX)
- Market cap
- $90.18B
- P/E
- 27.98
- Dividend yield
- 1.15%
- Street target
- $54.00median of 25 analysts
- 52-week range
- $33.63 $53.60
The short version
Where CSX stands today, in four lines, and what CleaRank Financial AI makes of it.
CSX at a glance
CSX Corporation (CSX): Buy, 64/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($44.86 and $48.79).
- Earnings CSX beat estimates in 4 of its last 7 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $18.6M and bought $3.0M over the last 18 months.
- Valuation P/E of 28.0 against 34.0 for the Industrials sector: broadly in line with peers (-18%).
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates CSX Corporation (CSX) a Buy with a model score of 64/100.
Trend is the biggest contributor, with the price 8.55% above its 200-day average and the 50-day average 8.77% above the 200-day. Valuation pulls the score down most, as the P/S of 6.22 is 55.5% above the sector median. The 50-day average is $48.79 and the 200-day is $44.86. Across the past year, the price climbed 35.26%.
Only on CleaRank
Figures we compute ourselves from CSX's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $48.69 is 0.2% below the 50-day simple moving average of $48.79.Price above its 200-day average ›
The price is 8.5% above the 200-day simple moving average of $44.86.50-day average above the 200-day ›
The 50-day average ($48.79) is 8.8% above the 200-day average ($44.86), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 75% of its 52-week range, between $33.63 and $53.60.
CSX share price
Pick a period: each tab shows how far CSX has moved over it, to the last close.
Today's trading
Where CSX sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 27.98 is 17.7% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 6.22 is 55.4% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $3.2B on revenue of $14.5B, a net margin of 22.2%.Beat estimates in most recent reports ›
CSX beat the EPS estimate in 4 of its last 7 reports.Pays a dividend ›
The trailing dividend yield is 1.15%, or $0.56 a share a year.
Key statistics
The headline figures for CSX.
As of October 17, 2026, CSX trades at $48.69, with a market value of $90.18B, a P/E ratio of 27.98 and a dividend yield of 1.15%.
What the numbers say
CleaRank Financial AI's reading of CSX's valuation, growth and risks.
CSX Corporation (CSX) trades at a P/E of 27.98, which is 17.7% below the 34.0 median for Industrials stocks, a level the peer comparison rates as broadly in line with peers. On sales, the price-to-sales ratio of 6.22 is 55.5% above the sector median of 4.0.
CSX is growing more slowly than its sector: revenue rose 10.10% in the latest year, while the sector median is 11.7%. Profitability is solid, with a net margin of 22.21%, an operating margin of 38.42%, and a return on equity of 24.36% that sits above the sector median of 17.8%. On the balance sheet, debt-to-equity comes in at 1.38. The trailing dividend yield is 1.15%, which works out to $0.56 per share each year.
CSX's most recent quarterly report, released on July 22, 2026, beat the estimate by 3.85%. Earnings came in at $0.54 a share versus an expected $0.52. In the first session after the report, the share price rose 5.77%.
The earnings record shows 4 beats in 7 reports, and every one of those beats was followed by a gain the next day. The April 22, 2026 report stands out among the earlier ones: a beat of 10.26%, after which the stock rose 6.95%. The consensus EPS estimate stands at $2.00 for this fiscal year and $2.28 for next, growth of 29.8% for the current year.
The price of CSX typically moves 1.02% on a given day, based on the 30-day standard deviation of its daily returns. Over the last 18 months, insiders sold $18.6M of stock and bought $3.0M. Insider sales are often planned ahead or made to cover taxes on vesting shares, so they tell less than open-market purchases do.
CSX against the Industrials sector
How CSX compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-18% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 6, 2025, CSX has gained 73.3% against a gain of 25.6% for XLI.
Performance against XLI
CSX and the Industrials sector fund over the same days.
Revenue and earnings
How much CSX sells, and how much of it becomes profit.
Revenue growth: Revenue fell 3.1% in FY2025 to $14.1B, from $14.5B a year earlier.
Profit margin: The net margin was 20.5% in FY2025, down from 23.9% the year before.
Profitable: CSX earned $2.9B in FY2025.
Earnings reality check
Did CSX beat what analysts expected, and how did the stock react?
Earnings record: CSX beat the analyst estimate in 4 of the last 7 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 22, 2026after close | $0.52 | $0.54 | +3.85% | +5.77% | +1.62% |
| Apr 22, 2026after close | $0.39 | $0.43 | +10.26% | +6.95% | +3.47% |
| Oct 16, 2025after close | $0.42 | $0.44 | +4.76% | +1.69% | -1.28% |
| Jul 23, 2025after close | $0.42 | $0.44 | +4.76% | +0.09% | +0.92% |
| Apr 16, 2025after close | $0.37 | $0.34 | -8.11% | +1.21% | +2.89% |
| Jan 23, 2025after close | $0.42 | $0.42 | +0.00% | -2.91% | -2.41% |
| Oct 16, 2024after close | $0.48 | $0.46 | -4.17% | -6.71% | -5.30% |
As of October 17, 2026, CSX has beaten the analyst EPS estimate in 4 of its last 7 reported quarters and rose in the first trading session after every one of those beats; its latest report, on July 22, 2026, came in 3.85% above the estimate and the stock moved +5.77% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 58.5, in neutral territory.RSI above 50 ›
An RSI of 58.5 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CSX
The score, the reasoning behind it, and what could move the price next.
CSX Corporation (CSX) shows a mixed trend. The stock is trading at $48.69, which is 0.21% below its 50-day average of $48.79, yet it is 8.55% above its 200-day average of $44.86. Near the top of its 52-week range, the price is 9.16% below the high of $53.60 and 44.78% above the low of $33.63. The 50-day average sits 8.77% above the 200-day, so the longer averages have yet to catch up with the softer recent price.
Short-term and long-term price action disagree. Over the past month the price climbed 1.63%, while over the past three months it slipped 4.08%. Across the past year it gained 35.26%. The 14-day RSI sits at 58.5, which is in the neutral zone, and the MACD line is negative.
Earnings beat ›
The July 22, 2026 report beat the EPS estimate by 3.85%, and the share price rose 5.77% in the first session after it.
Source: Earnings report, July 22, 2026
Rating reaffirmed ›
Citigroup kept its Neutral rating on October 7, 2026.
Source: Analyst action, Citigroup, October 7, 2026
- The two levels nearest the price are worth tracking: the 50-day SMA at $48.79 overhead and the 20-day EMA at $47.81 underneath.
- The 14-day RSI is 58.5, which is in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 signal stretched momentum.
- CSX beat estimates in 4 of the last 7 reports, and after the July 22, 2026 report the share price gained 5.77% in the first session.
CSX has a mixed trend, trading above its 200-day average of $44.86 but under its 50-day average of $48.79. Closing above the 50-day would flip both signals to upward, while closing below the 200-day would flip both to downward. On the way down, the first support is the 20-day EMA at $47.81, and on the way up, the first resistance is the 50-day SMA at $48.79.
Technical indicators
Momentum and trend for CSX, from its daily closes.
As of October 17, 2026, with CSX at $48.69, its 14-day RSI is 58.5 (neutral territory), its 50-day simple moving average is $48.79 and its 200-day is $44.86.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CSX moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, CSX's 1-year correlation of daily returns is +0.43 with S&P 500 (SPY), +0.32 with Nasdaq 100 (QQQ), +0.11 with Bitcoin (BTC) and +0.07 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
17 of 25 analysts rate it a buy or strong buy, 6 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $54.00 is 10.9% above the price.More buy ratings than three months ago ›
17 of 25 rate it a buy now, against 17 of 25 three months ago.
CSX Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | Citigroup | Maintains | Neutral |
| Oct 5, 2026 | JP Morgan | Maintains | Overweight |
| Oct 2, 2026 | Susquehanna | Maintains | Positive |
| Sep 18, 2026 | B of A Securities | Maintains | Buy |
| Jul 24, 2026 | Citigroup | Maintains | Neutral |
| Jul 23, 2026 | JP Morgan | Maintains | Overweight |
As of October 17, 2026, 25 Wall Street analysts cover CSX: 17 rate it a buy or strong buy, 6 a hold and 2 a sell or strong sell. Their 12-month price targets range from $32.00 to $60.00, with a median of $54.00, 10.9% above the price of $48.69.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CSX trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CSX's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CSX tends to move, against the market and on its own.
The long record
CSX's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.02% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 33.3%, from February 2020 to March 2020, regained by September 2020.Most 1-year holds ended higher ›
75% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $55,040, against $42,058 in the S&P 500 (SPY).
CSX Drawdowns & Recovery
As of October 17, 2026, CSX's worst peak-to-trough fall over the last 10 years with dividends reinvested was -33.3% (February 2020 to March 2020); it regained that peak by September 2020, 6 months after the low, and 75% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CSX in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CSX beat the S&P 500 over this period: $55,040 against $42,058.
A $10,000 investment in CSX in October 2016 would be worth about $55,040 today with dividends reinvested, compared with about $42,058 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CSX, and which have not.
Strongest month, November: an average of +7.50%, up in 8 of 10 years.
Weakest month, March: an average of -3.00%, up in 3 of 10 years.
This month, October: has averaged -0.06%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CSX's strongest calendar month has been November (average +7.50%, up in 8 of 10 years) and its weakest March (average -3.00%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CSX, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CSX today could grow to about $25,092 by 2036 in the base case, with a 90th-percentile outcome near $76,695 and a 10th-percentile outcome around $8,209. The simulation models price only; at today's 1.15% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
CSX Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $70.35 for CSX by 2030 in the base case, from $48.69 today (1.4x over 4 years). The 10th-percentile path ends near $34.70. These are outcomes of a Monte Carlo simulation run on CSX's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $37.49 | $53.38 | $76.00 | |
| 2028 | $35.51 | $58.53 | $96.46 | |
| 2029 | $34.80 | $64.17 | $118 | |
| 2030 | $34.70 | $70.35 | $143 | |
| 2031 | $35.00 | $77.13 | $170 |
Method: a lognormal simulation of CSX's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CSX insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $3.0M on the open market and sold $18.6M.
As of October 17, 2026, CSX insiders reported 9 open-market sales worth $18.6M and 2 open-market purchases worth $3.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Angela C Williams
Officer
|
Sell | 30.0K | $1.6M |
| Jul 24, 2026 | Michael S. Burns
Officer
|
Sell | 13.0K | $684.8K |
| Jul 24, 2026 | Michael S. Burns
Officer
|
Option | 13.0K | $344.5K |
| Jun 15, 2026 | J Steven Whisler
Director
|
Grant | 791 | $37.5K |
| Jun 3, 2026 | Kevin S Boone
Chief Financial Officer
|
Sell | 136.7K | $6.4M |
| Jun 3, 2026 | John J Zillmer
Director
|
Sell | 10.0K | $464.5K |
| Jun 3, 2026 | Kevin S Boone
Chief Financial Officer
|
Option | 136.7K | $3.2M |
| Mar 13, 2026 | J Steven Whisler
Director
|
Grant | 954 | $37.5K |
| Mar 6, 2026 | Stephen F Angel
Chief Executive Officer
|
Buy | 25.0K | $1.0M |
| Mar 2, 2026 | John J Zillmer
Director
|
Grant | 5.9K | - |
| Feb 26, 2026 | Stephen F Angel
Chief Executive Officer
|
Grant | 63.3K | - |
| Feb 26, 2026 | Ann Begeman
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Kevin S Boone
Chief Financial Officer
|
Grant | 15.2K | - |
| Feb 26, 2026 | Thomas P Ph.d. Bostick
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Michael S. Burns
Officer
|
Grant | 8.2K | - |
| Feb 26, 2026 | M Rizwan Chand
Officer
|
Grant | 11.7K | - |
| Feb 26, 2026 | Anne H Chow
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Michael A Cory
Chief Operating Officer
|
Grant | 15.2K | - |
| Feb 26, 2026 | Stephen Fortune
Chief Technology Officer
|
Grant | 10.9K | - |
| Feb 26, 2026 | Steven T Halverson
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Paul C. J.d. Hilal
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Maryclare T Kenney
Officer
|
Grant | 9.4K | - |
| Feb 26, 2026 | David M Moffett
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Linda H Riefler
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Suzanne M. Vautrinot
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | James L Wainscott
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | J Steven Whisler
Director
|
Grant | 4.5K | - |
| Feb 26, 2026 | Angela C Williams
Officer
|
Grant | 1.9K | - |
| Feb 26, 2026 | John J Zillmer
Director
|
Grant | 10.3K | - |
| Feb 19, 2026 | Diana B Sorfleet
Officer
|
Sell | 90.0K | $3.7M |
| Feb 19, 2026 | Diana B Sorfleet
Officer
|
Option | 90.0K | $1.8M |
| Feb 3, 2026 | Stephen Fortune
Chief Technology Officer
|
Sell | 31.5K | $1.2M |
| Feb 3, 2026 | Stephen Fortune
Chief Technology Officer
|
Option | 31.5K | $996.2K |
| Jan 28, 2026 | Diana B Sorfleet
Officer
|
Sell | 66.7K | $2.5M |
| Jan 23, 2026 | Kevin S Boone
Chief Financial Officer
|
Grant | 3.1K | - |
| Jan 23, 2026 | Michael S. Burns
Officer
|
Grant | 298 | - |
| Jan 23, 2026 | Michael A Cory
Chief Operating Officer
|
Grant | 2.4K | - |
| Jan 23, 2026 | Stephen Fortune
Chief Technology Officer
|
Grant | 2.3K | - |
| Jan 23, 2026 | Maryclare T Kenney
Officer
|
Grant | 355 | - |
| Jan 23, 2026 | Diana B Sorfleet
Officer
|
Grant | 2.3K | - |
| Jan 23, 2026 | Angela C Williams
Officer
|
Grant | 336 | - |
| Dec 15, 2025 | J Steven Whisler
Director
|
Grant | 1.7K | $62.5K |
| Dec 4, 2025 | Paul C. J.d. Hilal
Director
|
Grant | 10.0K | - |
| Nov 14, 2025 | Maryclare T Kenney
Officer
|
Grant | 1.3K | - |
| Oct 22, 2025 | Kevin S Boone
Officer
|
Sell | 31.1K | $1.1M |
| Oct 22, 2025 | Kevin S Boone
Officer
|
Option | 31.1K | $551.5K |
| Oct 20, 2025 | Michael S. Burns
Officer
|
Sell | 24.2K | $891.4K |
| Oct 20, 2025 | Stephen F Angel
Chief Executive Officer
|
Buy | 55.0K | $2.0M |
| Oct 20, 2025 | Michael S. Burns
Officer
|
Option | 24.2K | $488.1K |
| Sep 15, 2025 | J Steven Whisler
Director
|
Grant | 1.2K | $37.5K |
| Jun 13, 2025 | J Steven Whisler
Director
|
Grant | 1.2K | $37.5K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.